JP2011516565A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516565A5 JP2011516565A5 JP2011504152A JP2011504152A JP2011516565A5 JP 2011516565 A5 JP2011516565 A5 JP 2011516565A5 JP 2011504152 A JP2011504152 A JP 2011504152A JP 2011504152 A JP2011504152 A JP 2011504152A JP 2011516565 A5 JP2011516565 A5 JP 2011516565A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- stilbene
- agent
- trimethoxy
- angiogenesis inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4396408P | 2008-04-10 | 2008-04-10 | |
| US61/043,964 | 2008-04-10 | ||
| PCT/US2009/039899 WO2009126705A2 (en) | 2008-04-10 | 2009-04-08 | Induction of tumor hypoxia for cancer therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015001834A Division JP5944018B2 (ja) | 2008-04-10 | 2015-01-07 | 癌治療用腫瘍低酸素の誘発 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011516565A JP2011516565A (ja) | 2011-05-26 |
| JP2011516565A5 true JP2011516565A5 (https=) | 2012-04-05 |
| JP5731372B2 JP5731372B2 (ja) | 2015-06-10 |
Family
ID=41162569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011504152A Active JP5731372B2 (ja) | 2008-04-10 | 2009-04-08 | 癌治療用腫瘍低酸素の誘発 |
| JP2015001834A Active JP5944018B2 (ja) | 2008-04-10 | 2015-01-07 | 癌治療用腫瘍低酸素の誘発 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015001834A Active JP5944018B2 (ja) | 2008-04-10 | 2015-01-07 | 癌治療用腫瘍低酸素の誘発 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US8591921B2 (https=) |
| JP (2) | JP5731372B2 (https=) |
| KR (1) | KR101925436B1 (https=) |
| CN (2) | CN104043125B (https=) |
| TW (1) | TWI504391B (https=) |
| WO (1) | WO2009126705A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2592103Y2 (ja) | 1992-07-23 | 1999-03-17 | 東海旅客鉄道株式会社 | ケーブルトラフ |
| EP1896040B1 (en) | 2005-06-29 | 2012-08-01 | Threshold Pharmaceuticals, Inc. | Phosphoramidate alkylator prodrugs |
| CN104043125B (zh) | 2008-04-10 | 2018-01-12 | 弗吉尼亚州立邦联大学 | 诱导肿瘤缺氧以治疗癌症 |
| ES2877629T3 (es) * | 2010-07-12 | 2021-11-17 | Immunogenesis Inc | Administración de profármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer |
| EP2407161A1 (en) * | 2010-07-13 | 2012-01-18 | Sanofi | An antitumoral combination comprising ombrabulin and bevacizumab |
| US9402820B2 (en) | 2011-04-22 | 2016-08-02 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors |
| EP2793882A4 (en) | 2011-12-22 | 2015-04-29 | Threshold Pharmaceuticals Inc | ADMINISTRATION OF HYPOXIA-ACTIVATED PRODRUGS IN COMBINATION WITH CHK1 INHIBITORS FOR THE TREATMENT OF CANCER |
| CN102512692B (zh) * | 2012-01-16 | 2014-07-16 | 北京大学 | 肿瘤靶向栓塞治疗组合物及其制备方法 |
| AU2013204313C1 (en) * | 2012-06-01 | 2016-04-07 | Bionomics Limited | Combination Therapy |
| WO2015069489A1 (en) | 2013-11-06 | 2015-05-14 | Merck Patent Gmbh | Predictive biomarker for hypoxia-activated prodrug therapy |
| US10172815B2 (en) * | 2013-11-11 | 2019-01-08 | University Hospitals Cleveland Medical Center | Targeted treatment of anerobic cancer |
| US9586056B2 (en) * | 2014-07-03 | 2017-03-07 | Haniva Llc | Combination therapy for treating cancer and method for treating cancer using a combination therapy |
| ES2822557T3 (es) * | 2014-08-08 | 2021-05-04 | Poseida Therapeutics Inc | Composiciones y su uso para inducir la embolización microvascular de tumores mediada por nanopartículas |
| EP4548978A3 (en) | 2015-01-29 | 2025-08-06 | Oxyrase, Inc. | Methods for inhibiting tumor growth |
| EP3294313A4 (en) * | 2015-05-15 | 2019-04-17 | The General Hospital Corporation | METHODS RELATING TO THE PREVENTION AND TREATMENT OF DRUG RESISTANCE |
| US10456452B2 (en) | 2015-07-02 | 2019-10-29 | Poseida Therapeutics, Inc. | Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles |
| WO2017070606A1 (en) * | 2015-10-21 | 2017-04-27 | Teclison Limited | Compositions and methods for immune-mediated cancer therapy |
| US11213594B2 (en) | 2016-04-29 | 2022-01-04 | Poseida Therapeutics, Inc. | Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids |
| JP2019515011A (ja) * | 2016-05-13 | 2019-06-06 | テクリソン リミテッド | 肝臓組織を処置するための方法 |
| CN107007571B (zh) * | 2017-02-24 | 2020-08-21 | 福州市传染病医院 | 肿瘤微酸性敏感的铜-药物共配位自组装纳米粒及应用 |
| CN110051848A (zh) * | 2019-05-06 | 2019-07-26 | 中国科学院长春应用化学研究所 | 药物组合、应用以及抗肿瘤的药物 |
| CN110585214A (zh) * | 2019-09-25 | 2019-12-20 | 湖北大学 | 一种促进治疗肿瘤效果的纳米粒子及其合成方法 |
| CN110713596B (zh) * | 2019-11-08 | 2022-04-29 | 西北师范大学 | 肿瘤无导管栓塞用pH-还原双响应高分子栓塞剂及其合成 |
| CN112961082B (zh) * | 2021-02-22 | 2022-09-06 | 沈阳药科大学 | 一种血管阻断剂与双载药仿生脂质体联用的给药系统 |
| JP7730130B2 (ja) * | 2021-03-02 | 2025-08-27 | ドリームメディカルパートナーズ株式会社 | 塞栓材及びその製造方法 |
| US20250302394A1 (en) * | 2021-09-22 | 2025-10-02 | Board Of Regents, The University Of Texas System | Quantitative magnetic resonance imaging and tumor forecasting |
| CN114344482B (zh) * | 2022-01-14 | 2023-05-12 | 重庆医科大学附属第二医院 | 一种基于金属有机骨架的多功能纳米粒及其制备方法与应用 |
| WO2024006901A1 (en) * | 2022-06-29 | 2024-01-04 | Diffusion Pharmaceuticals Llc | Uses of bipolar trans carotenoids in the treatment of cancer |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3980779A (en) | 1972-02-01 | 1976-09-14 | Bayer Aktiengesellschaft | 3-Amino-1,2,4-benzotriazine-1,4-di-N-oxide compositions and method of using same |
| US5616584A (en) | 1986-09-25 | 1997-04-01 | Sri International | 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| US5175287A (en) | 1986-09-25 | 1992-12-29 | S R I International | Process for preparing 1,2,4-benzotriazine oxides |
| ATE130517T1 (de) * | 1990-08-08 | 1995-12-15 | Takeda Chemical Industries Ltd | Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff. |
| CA2472404A1 (en) | 1993-07-19 | 1995-02-02 | Angiotech Pharmaceuticals, Inc. | Combination of stent and anti-angiogenic factor |
| US5484612A (en) | 1993-09-22 | 1996-01-16 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin |
| GB9404400D0 (en) | 1994-03-07 | 1994-04-20 | Wood Pauline J | Potentiation of bioreductive agents |
| EP1014990B1 (en) | 1997-03-07 | 2006-09-06 | Sanofi-Aventis U.S. LLC | Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum |
| DE10012120A1 (de) | 2000-03-13 | 2001-09-27 | Ktb Tumorforschungs Gmbh | Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel |
| CN1555253A (zh) * | 2001-09-13 | 2004-12-15 | ������ѧ�����о�Ժ | 化疗栓塞用紫杉醇的油性组合物、制剂及它们的制造方法 |
| EP1599196A4 (en) * | 2003-01-17 | 2006-05-31 | Threshold Pharmaceuticals Inc | COMBINATION THERAPIES FOR CANCER TREATMENT |
| US20060264388A1 (en) | 2003-02-26 | 2006-11-23 | Olga Valota | Method for treating liver cancer by intrahepatic administration of nemorubicin |
| ITRM20030355A1 (it) | 2003-07-18 | 2005-01-19 | Sigma Tau Ind Farmaceuti | Composti ad attivita' citotossica derivati della combretastatina. |
| US20080108664A1 (en) | 2005-12-23 | 2008-05-08 | Liu Belle B | Solid-state form of AMG 706 and pharmaceutical compositions thereof |
| CN104043125B (zh) | 2008-04-10 | 2018-01-12 | 弗吉尼亚州立邦联大学 | 诱导肿瘤缺氧以治疗癌症 |
-
2009
- 2009-04-08 CN CN201310699012.3A patent/CN104043125B/zh active Active
- 2009-04-08 JP JP2011504152A patent/JP5731372B2/ja active Active
- 2009-04-08 CN CN200980102782.7A patent/CN102026634B/zh active Active
- 2009-04-08 US US12/922,658 patent/US8591921B2/en active Active
- 2009-04-08 KR KR1020107025113A patent/KR101925436B1/ko active Active
- 2009-04-08 WO PCT/US2009/039899 patent/WO2009126705A2/en not_active Ceased
- 2009-04-09 TW TW098111832A patent/TWI504391B/zh active
-
2013
- 2013-10-01 US US14/043,661 patent/US9649316B2/en active Active
-
2015
- 2015-01-07 JP JP2015001834A patent/JP5944018B2/ja active Active
-
2017
- 2017-04-05 US US15/480,250 patent/US10426779B2/en active Active
- 2017-04-05 US US15/480,242 patent/US10159676B2/en active Active - Reinstated
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516565A5 (https=) | ||
| CN104043125B (zh) | 诱导肿瘤缺氧以治疗癌症 | |
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| CY1119001T1 (el) | Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για ανευ νοηματος καταστολη και τη θεραπεια ασθενειας | |
| JP2019507179A5 (https=) | ||
| RU2420522C2 (ru) | Новый класс ингибиторов гистондеацетилаз | |
| JP5767122B2 (ja) | 特定の癌の治療のためのｒｄｅａ１１９／ｂａｙ８６９７６６を含む組み合わせ医薬 | |
| JP2013513612A5 (https=) | ||
| JP2012519694A5 (https=) | ||
| JP2017530983A5 (https=) | ||
| JP2010526840A5 (https=) | ||
| JP2008531479A5 (https=) | ||
| JP2008521827A5 (https=) | ||
| JP2006522813A5 (https=) | ||
| CN115803328A (zh) | 哌嗪-2,3-二酮衍生物及其在医药上的应用 | |
| RU2012158142A (ru) | Противоопухолевое средство, задействующее соединения с ингибирующим эффектом к киназам в комбинации | |
| AR080472A1 (es) | Terapias de inhibidor de autofagia basado en tioxantona para tratar el cancer | |
| JP5788527B2 (ja) | キナーゼ阻害剤の副作用低減剤 | |
| JP2009538276A5 (https=) | ||
| CY1112637T1 (el) | Παραγων για την προληψη και αγωγη των παθησεων του ηπατος περιεχοντας παραγωγο πυραζολοπυριμιδινης | |
| JP2017512211A5 (https=) | ||
| ES2337848T3 (es) | Formulaciones de valsartan. | |
| CL2024001520A1 (es) | Nueva composición farmacéutica oral y régimen de dosificación para la terapia de enfermedades pulmonares intersticiales | |
| EA201101305A1 (ru) | Лечение рака поджелудочной железы | |
| RU2007137115A (ru) | Новые офтальмологические композиции и способы их применения |